PyInvesting

Market research

RMD.AU ResMed Inc

AU AUD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
44B
P/E ratio
20.9
Analyst target
39.521
Dividend yield
7.9%
Beta
0.77

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

ResMed Inc is currently in a long term uptrend where the price is trading 23.6% above its 200 day moving average.

From a valuation standpoint, the stock is 96.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.2.

ResMed Inc's total revenue rose by 8.7% to $800M since the same quarter in the previous year.

Its net income has increased by 11.8% to $180M since the same quarter in the previous year.

Finally, its free cash flow grew by 680.6% to $135M since the same quarter in the previous year.

Based on the above factors, ResMed Inc gets an overall score of 5/5.